PGI9 SURGERY-RELATED COSTS AVERTED BY THE USE OF BIOLOGIC DRUGS FOR THE TREATMENT OF CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE CALCULATED THROUGH A MATHEMATICAL MODEL
May 1, 2019, 00:00
10.1016/j.jval.2019.04.780
https://www.valueinhealthjournal.com/article/S1098-3015(19)30972-6/fulltext
Title :
PGI9 SURGERY-RELATED COSTS AVERTED BY THE USE OF BIOLOGIC DRUGS FOR THE TREATMENT OF CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE CALCULATED THROUGH A MATHEMATICAL MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30972-6&doi=10.1016/j.jval.2019.04.780
First page :
Section Title :
Open access? :
No
Section Order :
10365